License for Quality
Integrate the quality management systems operations across the global enterprise, fostering compliance with GxP.
Accelerate therapeutic development, approval, manufacturing, and supply, in a global landscape
Pharmaceutical and Biotechnology companies are challenged with the ability to deliver operational excellence with full traceability and to efficiently manage the ever changing global regulatory environment. License to Cure for BioPharma is an Industry Solution Experience that uniquely provides the ability to accelerate therapeutic development, approval, manufacturing, and supply, in a global landscape by leveraging an extensive, connected and comprehensive regulatory and quality platform.
License to Cure for BioPharma provides digital continuity for organizations to manage the complexity of an ever increasing number of medicinal products with a single version of the truth based on IDMP standards and enables change impact analysis, informed decision making and full IP reuse to deliver quality best practices shifting the paradigm of regulatory as a constraint to regulatory as an asset.
Pharma and biotech organizations need game-changing ideas to survive as they look for ways to accelerate innovation and improve efficiency. One area ready for transformational change is the product lifecycle management process (PLM).
Axendia’s latest white paper: “The Key to Bio-Pharma Transformation” will explore how Pharmaceuitcal and Biotech companies can benefit by adopting a more holistic approach to PLM to accelerate innovation cycles and innovate through digital continuity.
Transition from a traditional product oriented model to the delivery of therapeutic solutions using a system that enables companies to be more reactive to quickly meet today's market needs.
Spend less time, reduce the risk of non-compliance, improve traceability and accelerate global expansion
Enhance decision-making through real-time views across the lifecycle of innovation
The 3DEXPERIENCE® platform enables businesses to transition from historical and outdated practices to a connected and transformative environment across your extended ecosystem.
License to Cure for BioPharma provides digital continuity for organizations to manage the complexity of an ever increasing number of medicinal products with a single version of the truth.
Learn how Biogen addressed a challenge that is common with many pharma and biopharmaceutical companies: how to reduce inefficiency and improve the delivery of crucial documentation.
Accelerate therapeutic approval, production, and patient adoption in a global landscape